HCA HEALTHCARE INC
HCANYSETrading Snapshot
- Day Range
- $408.57 – $416.90
- 52-Week Range
- $353.99 – $556.52
- Volume
- $2.45B
- Avg Volume
- $2.12B
- Shares Outstanding
- 216.5M
- Next Earnings
- Oct 10, 2026
Fundamentals Snapshot
- Annual Revenue
- $78.34B
- Last Q Revenue
- $20.01B
- P/E Ratio
- 13.0
- P/S Ratio
- 1.1x
- EPS (TTM)
- $29.87
- Dividend Yield
- 0.76%
Why Investors Own HCA
- ✓High-growth profile — revenue up +3.4% YoY with expanding US Equity exposure.
- ✓Healthy economics — 40% gross margin and 15% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About HCA HEALTHCARE INC
A company profile for HCA HEALTHCARE INC isn’t available yet — check back soon.
Otter Score Breakdown
ⓘAnalyst Ratings
ⓘLatest News & Updates
ResMed Q4 Earnings Call Highlights
ResMed (NYSE:RMD) reported fourth-quarter fiscal 2026 revenue growth of 9% on a reported basis, or 8% in constant currency, as demand for sleep devices and masks increased. Non-GAAP earnings per share rose 16% to $2.95, while the company expanded gross margin despite continued inflation in electroni
Top 50 High-Quality Dividend Growth Stocks For August 2026
I track a curated universe of 50 high-quality dividend growth stocks to identify timely, attractive entry points for long-term total return. Check out the list here.
Which S&P500 stocks are moving before the opening bell on Friday?
Before the opening bell on Friday, let's take a glimpse of the US markets and explore the S&P500 top gainers and losers in today's pre-market session.
Outset Medical Q2 Earnings Call Highlights
Outset Medical (NASDAQ:OM) reported second-quarter 2026 revenue of $31.6 million, up 1% from a year earlier and 14% sequentially, as the dialysis technology company cited commercial progress, improving margins and a new $40 million refresh agreement with HCA Healthcare. Chair and Chief Executive Of
Outset Medical Reports Second Quarter 2026 Results
SAN JOSE, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity, today reported financial results for the second quarter ended June 30, 2026. Second Quarter and Recent Highlights Net revenue totaled $31.6 million, an increase of 1% compared to the prior-year period and an increase of 14% sequentially.Recurring revenue, consisting of
HCA Healthcare Announces Dr. Michael Schlosser as Executive Vice President and Chief Clinical Officer; Names Charles Gressle President of New Ambulatory Operations Group
NASHVILLE, Tenn., August 06, 2026--HCA Healthcare, Inc. (NYSE:HCA) today announced that Michael Schlosser, M.D., MBA, senior vice president and chief transformation officer, has been appointed executive vice president and chief clinical officer, effective Sept. 1, 2026.